UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate

PloS one, 2012-07, Vol.7 (7), p.e41281-e41281

2012

Volltextzugriff (PDF)

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy

Circulation. Heart failure, 2015-01, Vol.8 (1), p.71-78

2015

Volltextzugriff (PDF)

Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome

American journal of physiology. Renal physiology, 2016-07, Vol.311 (1), p.F52-F62

2016

Volltextzugriff (PDF)

Cardiorenal syndrome: Multi‐organ dysfunction involving the heart, kidney and vasculature

British journal of pharmacology, 2020-07, Vol.177 (13), p.2906-2922

2020

Volltextzugriff (PDF)

Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?

European heart journal, 2010-07, Vol.31 (14), p.1771-1779

2010

Volltextzugriff (PDF)

Cardiorenal Syndrome: The Emerging Role of Protein-Bound Uremic Toxins

Circulation research, 2012-11, Vol.111 (11), p.1470-1483

2012

Volltextzugriff (PDF)

The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction

PloS one, 2013-12, Vol.8 (12), p.e83687-e83687

2013

Volltextzugriff (PDF)

Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction

International journal of cardiology, 2018-05, Vol.258, p.192-198

2018

Volltextzugriff (PDF)

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

European journal of preventive cardiology, 2021-08, Vol.28 (9), p.975-982

2021

Volltextzugriff (PDF)

Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction

Cardiovascular research, 2021-02, Vol.117 (3), p.918-929

2021

Volltextzugriff (PDF)

Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings

Toxins, 2022-01, Vol.14 (2), p.100

2022

Volltextzugriff (PDF)

Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome

American journal of physiology. Heart and circulatory physiology, 2012-05, Vol.302 (9), p.H1884-H1893

2012

Volltextzugriff (PDF)

The Preventable Productivity Burden of Kidney Disease in Australia

Journal of the American Society of Nephrology, 2021-04, Vol.32 (4), p.938-949

2021

Volltextzugriff (PDF)

The impact of coronary heart disease prevention on work productivity: a 10-year analysis

European journal of preventive cardiology, 2021-05, Vol.28 (4), p.418-425

2021

Volltextzugriff (PDF)

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

Circulation. Heart failure, 2013-05, Vol.6 (3), p.594-605

2013

Volltextzugriff (PDF)

Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects

Life sciences (1973), 2021-05, Vol.272, p.119267, Article 119267

2021

Volltextzugriff (PDF)

Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?

Journal of thoracic disease, 2016-09, Vol.8 (9), p.E1068-E1071

Kompa, Andrew R

2016

Volltextzugriff (PDF)

NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction

Life sciences (1973), 2022-01, Vol.289, p.120220-120220, Article 120220

2022

Volltextzugriff (PDF)

Cardiac tissue engineering in an in vivo vascularized chamber

Circulation (New York, N.Y.), 2007-01, Vol.115 (3), p.353-360

2007

Volltextzugriff (PDF)

A practical guide to subtotal nephrectomy in the rat with subsequent methodology for assessing renal and cardiac function

Nephrology (Carlton, Vic.), 2014-09, Vol.19 (9), p.552-561

2014

Volltextzugriff (PDF)

Protein kinases as cardiovascular therapeutic targets

The Lancet (British edition), 2014-09, Vol.384 (9949), p.1162-1164

2014

Volltextzugriff (PDF)

Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome

International journal of cardiology, 2020-07, Vol.310, p.128-136

2020

Volltextzugriff (PDF)

Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition

Toxicology letters, 2021-10, Vol.350, p.133-142

2021

Volltextzugriff (PDF)

Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction

Autonomic neuroscience, 2014-10, Vol.185, p.43-50

2014

Volltextzugriff (PDF)

RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis

International journal of cardiology, 2021-03, Vol.326, p.156-156

2021

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy

Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome

Cardiorenal syndrome: Multi‐organ dysfunction involving the heart, kidney and vasculature

Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?

Cardiorenal Syndrome: The Emerging Role of Protein-Bound Uremic Toxins

The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction

Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction

Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings

Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome

The Preventable Productivity Burden of Kidney Disease in Australia

The impact of coronary heart disease prevention on work productivity: a 10-year analysis

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects

Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?

NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction

Cardiac tissue engineering in an in vivo vascularized chamber

A practical guide to subtotal nephrectomy in the rat with subsequent methodology for assessing renal and cardiac function

Protein kinases as cardiovascular therapeutic targets

Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome

Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition

Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction

RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis

Suchergebnisse filtern